0 items USD 0.00Search
- Did you mean
- biosimilar
Your search for "biosimilars" gave back 54 results.
The global Biosimilar of Remicade market size was valued at US$ 292500 million in 2023. With growing demand in downstream market, the Biosimilar of...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Biosimilar Development Services market size was valued at USD 113430 million in 2023 and is forecast to a readjusted size of USD 220380...
Catalog:
GIR
February 2024
Price: USD 3,480.00
The global Biosimilar Development Services market size was valued at US$ 107840 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
January 2024
Price: USD 3,660.00
A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The Biosimilar Development Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Biosimilars & Follow-on-Biologics market was valued at US$ 22490 million in 2023 and is anticipated to reach US$ 52070 million by 2030...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The increasing popularity of biosimilars in treating diseases, such as cancer, autoimmune diseases, blood disorders, and others, and the low cost of...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Biosimilar Contract Manufacturing market will undergo...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Biosimilar Contract Manufacturing market will undergo...
Catalog:
Arsta
November 2022
Price: USD 3,360.00
The increasing popularity of biosimilars in treating diseases, such as cancer, autoimmune diseases, blood disorders, and others, and the low cost of...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
